| 1994 |
Rab6 controls intra-Golgi transport, specifically between cis/medial and late (trans) Golgi compartments; overexpression of GTP-bound (Q72L) or wild-type Rab6 blocks transport between these compartments without affecting ER-to-cis/medial Golgi or TGN-to-plasma membrane transport. |
Transient overexpression of wild-type, GTP-bound (Q72L) and GDP-bound (T27N) mutants in HeLa and L cells; intracellular transport assays with SEAP and influenza HA |
The Journal of cell biology |
High |
7798313
|
| 1994 |
Golgi apparatus localization of Rab6 requires geranylgeranylation at its CXC C-terminal motif and sequences within the N-terminal 71 amino acids (including the effector domain); farnesylation alone cannot substitute for geranylgeranylation in Golgi targeting. |
Chimeric Ras-Rab proteins, C-terminal lipid modification mutants, immunofluorescence, yeast complementation assay |
Molecular and cellular biology |
High |
8264642
|
| 1994 |
Geranylgeranylation on CXC or CC motifs is required for efficient membrane extraction of Rab6 by RabGDI; the effector domain, loop3/beta3, and hypervariable region of Rab6 are all required for RabGDI binding, while loop3/beta3 and hypervariable region (but not the effector domain) are required for RabGGTase processing. |
In vitro RabGDI membrane extraction assay with Rab6 mutants carrying various C-terminal lipid modifications; mutagenesis |
The Journal of biological chemistry |
High |
8175798
|
| 1995 |
GDI beta interacts with wild-type Rab6 and Rab5 but not with a GTP-bound Rab6 mutant, and recombinant GDI beta can remove Rab6 (and other Rabs including Rab1, Rab2, Rab4) from membranes. |
Yeast two-hybrid screen; recombinant GDI beta membrane extraction assay |
The Journal of biological chemistry |
High |
7782346
|
| 1996 |
Rab6 antibodies and a trans-dominant Rab6 mutant (N126I) inhibit transport between cis and medial Golgi cisternae and inhibit fusion of Golgi membranes in a cell-free reconstituted transport system, indicating Rab6 is required for membrane fusion at Golgi cisternal membranes. |
Reconstituted in vitro Golgi transport assay; inhibition with polyclonal antibodies, Fab fragments, and dominant-negative Rab6 N126I mutant |
The Journal of biological chemistry |
High |
8663167
|
| 1997 |
GTP-bound Rab6 (Q72L) and wild-type Rab6 overexpression induces microtubule-dependent redistribution of trans-Golgi proteins (beta-1,4-galactosyltransferase) into the ER, phenocopying brefeldin A effects; this retrograde Golgi-to-ER transport requires intact microtubules. |
Overexpression of wild-type and GTP/GDP mutants of Rab6 in HeLa cells; immunofluorescence and biochemical analyses; microtubule depolymerization experiments |
Proceedings of the National Academy of Sciences of the United States of America |
High |
9050864
|
| 1998 |
Rab6 binds specifically to the GTP-bound form of Rab6, and this interaction is mediated by the C-terminal domain of Rabkinesin-6 (KIF20A); Rabkinesin-6 localizes to the Golgi apparatus and its overexpression (C-terminal domain) inhibits Rab6-GTP effects on intracellular transport, identifying a kinesin motor as a Rab6 effector. |
Two-hybrid screen; co-immunoprecipitation; immunofluorescence localization; dominant-negative overexpression transport assay |
Science |
High |
9438855
|
| 1999 |
Rab6 regulates a COPI-independent Golgi-to-ER retrograde transport pathway; Rab6-positive transport carriers specifically carry retrograde cargo (Shiga toxin B-fragment) and associate with ER; Rab6:GDP (T27N) overexpression inhibits Shiga holotoxin cytotoxicity without blocking STB transport to the Golgi; COPI markers are excluded from Rab6/STB transport carriers. |
Live fluorescence imaging of FP-Rab6 with secretory pathway markers; COPI antibody microinjection; vaccinia-T7 overexpression of Rab6 T27N; confocal and time-lapse microscopy |
The Journal of cell biology |
High |
10562278
|
| 1999 |
GAPCenA is a novel GAP specifically active on Rab6 in vitro (and to lesser extent on Rab4 and Rab2); GAPCenA is predominantly cytosolic with a minor pool at the centrosome, forms complexes with gamma-tubulin, and plays a role in microtubule nucleation. |
In vitro GAP activity assay on recombinant Rab proteins; immunofluorescence; cell fractionation; co-immunoprecipitation with gamma-tubulin |
The EMBO journal |
High |
10202141
|
| 1999 |
Golgins golgin-230/245/256 and golgin-97 target to the Golgi apparatus through a conserved C-terminal domain containing a critical tyrosine residue that preferentially binds Rab6; mutations abolishing Golgi targeting also abolish Rab6 binding, identifying a Rab6-interacting domain defining a family of Golgi-targeted coiled-coil proteins. |
Protein blot binding assay; mutagenesis; Golgi targeting assays; sequence analysis |
Current biology |
High |
10209123
|
| 2000 |
Rab6A and Rab6A' are two distinct isoforms generated by alternative splicing of the RAB6A gene, differing in only 3 amino acids near the PM3 GTP-binding domain; Rab6A' does not bind Rabkinesin-6 (a Rab6A effector) due to a single amino acid difference at position 87 (T vs A), and Rab6A' overexpression does not induce redistribution of Golgi proteins to ER as Rab6A does. |
Molecular cloning and sequencing of human RAB6A gene; GTP-binding assays; immunofluorescence; yeast two-hybrid interaction with Rabkinesin-6 and GAPCenA; GTP-bound mutant overexpression in HeLa cells |
Molecular biology of the cell |
High |
11071909
|
| 2000 |
Rab6-KIFL (KIF20A) accumulates in mitotic cells at the spindle midzone during anaphase and at the cleavage furrow and midbody during telophase; microinjection of anti-Rab6-KIFL antibodies causes cytokinesis failure (binucleate cells) by defecting cleavage furrow formation. |
Immunofluorescence; time-lapse microscopy; microinjection of inhibitory antibodies; overexpression cytokinesis assay |
The EMBO journal |
High |
11060022
|
| 2002 |
Rab6a' (but not Rab6a) is required for early/recycling endosome-to-TGN retrograde transport, working together with specific SNARE complexes (syntaxin 6, syntaxin 16, Vti1a with VAMP3/cellubrevin or VAMP4); Rab6a has been implicated in Golgi-to-ER transport. |
Permeabilized cell retrograde transport assay; identification of SNARE interactions; functional depletion/inhibition studies |
The Journal of cell biology |
High |
11839770
|
| 2002 |
Dynactin binds specifically to Rab6 (but not to other Golgi Rabs) and shows Rab6-dependent recruitment to Golgi membranes; Rab6 acts as a specificity factor controlling dynactin recruitment to membranes. |
Pulldown assays; immunofluorescence; Golgi membrane recruitment assay with dominant-negative and active Rab6 mutants |
Current biology |
High |
12401177
|
| 2002 |
Rab6IP2A and Rab6IP2B specifically interact with all three Rab6 isoforms (Rab6A, A', B); they are recruited to Golgi membranes in a Rab6:GTP-dependent manner; overexpression of the Rab6-binding domain of Rab6IP2 inhibits retrograde transport of Shiga toxin B subunit from plasma membrane to Golgi, suggesting Rab6IP2 functions in the Rab6A'-regulated pathway. |
Yeast two-hybrid screen; Golgi membrane recruitment assay; Shiga toxin retrograde transport assay |
Traffic |
Medium |
11929610
|
| 2003 |
Phage display-derived recombinant antibodies specific to GTP-bound Rab6 revealed that Rab6 is in its GTP-bound conformation on the Golgi apparatus and on transport intermediates; Rab6 GTPase activity modulates the geometry/morphology of transport intermediates. |
Antibody phage display; intracellular expression of GFP-tagged conformation-specific antibodies; live-cell imaging |
Science |
High |
12738866
|
| 2004 |
Both Rab6A and Rab6A' GTP-restricted mutants promote microtubule-dependent recycling of Golgi resident glycosylation enzymes to the ER with similar efficiency; this Rab6-directed Golgi-to-ER recycling requires functional dynactin (inhibited by p50/dynamitin overexpression or C-terminal Bicaudal-D fragment), and is initiated from the trans-Golgi network. |
siRNA knockdown; overexpression of GTP-restricted mutants; live imaging; p50/dynamitin dominant-negative overexpression |
Molecular biology of the cell |
High |
15483056
|
| 2004 |
TMF/ARA160 is a Golgi golgin that binds to all three Rab6 isoforms; depletion of TMF by RNAi causes modest dispersal of Golgi membranes, indicating a role in Golgi organization. |
Co-immunoprecipitation; RNAi knockdown; immunofluorescence; sequence-based identification of conserved Rab6-binding motif |
BMC cell biology |
Medium |
15128430
|
| 2006 |
Rab6A' (but not Rab6A) is required for cell cycle progression through mitosis; Rab6A' alteration blocks cells in metaphase with the Mad2-spindle checkpoint activated; the Rab6 effector p150(Glued) (dynactin subunit) remains associated with kinetochores; GAPCenA depletion produces a similar phenotype, suggesting Rab6A' regulates dynein/dynactin dynamics at kinetochores for the metaphase/anaphase transition. |
siRNA knockdown of Rab6A'; time-lapse microscopy; immunofluorescence for spindle checkpoint markers; co-depletion of GAPCenA |
The EMBO journal |
High |
16395330
|
| 2006 |
Rab6A and Rab6A' perform non-overlapping functions: Rab6A' knockdown (but not Rab6A) hampers retrograde transport of Shiga Toxin B-subunit and causes defects in Golgi-associated protein recycling through the ER; Rab6A' is required for cell cycle progression through mitosis; Ile62 is a key residue uncoupling Rab6A' functions in mitosis versus retrograde trafficking. |
siRNA with isoform-specific oligonucleotides; Shiga Toxin B retrograde transport assay; cell cycle analysis; mutagenesis of Ile62 |
Traffic |
High |
16536738
|
| 2007 |
Rab6 marks exocytotic vesicles and, together with kinesin-1, stimulates processive microtubule-based transport to the cell periphery; Rab6 directs targeting of secretory vesicles to plasma-membrane sites enriched in the cortical protein ELKS. |
Live-cell imaging; siRNA knockdown; co-immunoprecipitation; identification of ELKS as Rab6 effector; vesicle motility assays |
Developmental cell |
High |
17681140
|
| 2007 |
TMF/ARA160 knockdown blocks retrograde transport of Shiga toxin from early/recycling endosomes to TGN and causes Rab6-dependent displacement of GalNAc-T2 (but not GalT) from the Golgi; the cytoplasmic region of GalNAc-T2 is critical for TMF-dependent Golgi retention. |
RNAi knockdown of TMF and Rab6; Shiga toxin retrograde transport assay; immunofluorescence; chimeric protein analysis |
Experimental cell research |
High |
17698061
|
| 2007 |
Rab6 regulates two distinct retrograde Golgi trafficking pathways involving ZW10/RINT-1 and COG complexes; epistatic Rab6 depletion suppresses Golgi disruption caused by ZW10/RINT-1 or COG inactivation; BicaudalD C-terminal fragment (linking Rab6 to dynactin/dynein) suppresses ZW10 but not COG knockdown-induced disruption. |
siRNA epistasis experiments; dominant-negative Rab6 and BicaudalD expression; immunofluorescence; multiple depletion combinations |
Molecular biology of the cell |
High |
17699596
|
| 2007 |
Rab6-interacting protein 1 (R6IP1) binds both Rab6 (GTP-bound) and Rab11A (GTP-bound); R6IP1 is targeted to the Golgi in a Rab6-dependent manner; overexpression of R6IP1 promotes Rab11A–Rab6 interaction (detected by FRET/FLIM) and accumulates recycling endosomes in the pericentriolar area; R6IP1 function is required during metaphase and cytokinesis. |
Co-immunoprecipitation; FRET/FLIM in live cells; subcellular localization; dominant-negative and siRNA experiments; cell cycle analysis |
Traffic |
High |
17725553
|
| 2008 |
Rab6 GTPase interacts with gerodermia osteodysplastica protein SCYL1BP1 (GORAB); GORAB localizes to the Golgi apparatus; loss-of-function mutations in SCYL1BP1 cause gerodermia osteodysplastica, linking Rab6-associated secretory pathway abnormalities to this connective tissue disorder. |
Identification of disease mutations; co-localization studies; protein interaction assay |
Nature genetics |
Medium |
18997784
|
| 2008 |
DYNLRB1 (dynein light chain) specifically interacts with all three Rab6 isoforms; DYNLRB1 shows preferred association with GTP-bound Rab6A and GDP-bound Rab6A'/Rab6B; DYNLRB1 co-localizes with Rab6 at the Golgi apparatus, representing the first direct interaction between Rab6 and the dynein complex. |
Yeast two-hybrid; co-immunoprecipitation; pulldown assays; immunofluorescence co-localization |
Cell motility and the cytoskeleton |
High |
18044744
|
| 2008 |
Rab6a interacts with effectors BicaudalD2, p150(Glued), and PIST through their coiled-coil domains; all three bind GTP-bound Rab6a with Kd in high nanomolar to low micromolar range; BicaudalD2 and p150 binding moderately inhibits Rab6a intrinsic GTPase activity; effectors display rapid on- and off-rates (single-step binding kinetics). |
In vitro binding/biophysical assays (ITC, fluorescence); GTPase activity assays; transient kinetic analysis |
The Journal of biological chemistry |
High |
19019823
|
| 2009 |
Crystal structure of Rab6a-GTP in complex with a 378-residue fragment of Rab6IP1 was solved at 3.2 Å; the first and last alpha-helices of the RUN domain of Rab6IP1 mediate binding to switch I, switch II, and interswitch region of Rab6; comparison with GCC185 complex reveals conformational flexibility in Rab6's hydrophobic triad mediates recognition of distinct effectors. |
X-ray crystallography; structural comparison with Rab6-GCC185 complex |
Structure |
High |
19141279
|
| 2010 |
BICDR-1 is a Rab6 effector that interacts with kinesin Kif1C and the dynein/dynactin complex; BICDR-1 regulates pericentrosomal localization of Rab6-positive secretory vesicles and restricts anterograde secretory transport, inhibiting neuritogenesis in early neuronal development; BICDR-1 is required for neural development in zebrafish. |
Co-immunoprecipitation; live-cell imaging; siRNA knockdown; zebrafish knockdown; fluorescence microscopy |
The EMBO journal |
High |
20360680
|
| 2011 |
Rab8A stably associates with exocytotic vesicles in a Rab6-dependent manner; Rab8A is required for docking and fusion of exocytotic carriers (not for budding or motility); Rab8A and ELKS act in the same pathway; MICAL3 links Rab8A and ELKS, and its monooxygenase activity is required for its own turnover and remodeling of vesicle-docking protein complexes. |
Live-cell imaging; siRNA knockdown; co-immunoprecipitation; dominant-negative MICAL3 expression; vesicle tracking |
Current biology |
High |
21596566
|
| 2012 |
Human Ric1 and Rgp1 form a complex that acts as the guanine nucleotide exchange factor (GEF) for Rab6A, binding preferentially to GDP-bound Rab6A and catalyzing nucleotide exchange; Rab33B-GTP binds Ric1 at a distinct site, linking medial and late Golgi Rab proteins in a cascade; loss of Ric1 or Rgp1 destabilizes Rab6 and blocks Rab6-dependent retrograde transport of mannose-6-phosphate receptors. |
In vitro GEF nucleotide exchange assay; co-immunoprecipitation; siRNA knockdown with transport assay; binding assays |
The Journal of biological chemistry |
High |
23091056
|
| 2012 |
Rab6 depletion by electron tomography reveals accumulation of two classes of coated vesicles (clathrin-coated and COPI-coated) at the trans-Golgi/TGN and a >50% increase in Golgi cisternal number; Rab6 is essential for trafficking of these vesicles, and Golgi-to-cell-surface transport is delayed. |
Electron tomography; siRNA knockdown; electron microscopy; VSV-G cargo transport kinetics |
Traffic |
High |
22335553
|
| 2013 |
Rab6 depletion reduces TNF delivery to the cell surface in macrophages; Rab6-GFP localizes on TGN-derived tubular carriers marked by golgin p230; Rab6 depletion and inactive mutants alter tubular carrier egress and reduce p230 membrane association, suggesting Rab6 stabilizes p230 on tubular carriers to facilitate TNF transport. |
siRNA/shRNA knockdown; live-cell imaging; dominant-negative mutants; electron microscopy; TNF secretion ELISA |
PloS one |
High |
23437303
|
| 2014 |
COH1 (VPS13B) association with the Golgi complex depends on Rab6; RAB6A/A' knockdown prevents COH1 Golgi localization; constitutively active RAB6_Q72L preferentially co-immunoprecipitates with COH1, identifying COH1 as a RAB6 effector; COH1 depletion in neurons impairs neurite outgrowth. |
RNAi knockdown of RAB6A/A'; co-immunoprecipitation with active/inactive RAB6 mutants; membrane solubilization; primary neuron knockdown with morphological readout |
The Journal of biological chemistry |
High |
25492866
|
| 2015 |
KIF1C transports Rab6A-positive vesicles and can influence Golgi organization; KIF1C binds Rab6A directly both via its motor domain and C-terminus; Rab6A binding to the KIF1C motor domain inhibits microtubule interaction in vitro and in cells, decreasing the amount of motile KIF1C; KIF1C depletion slows protein delivery to the cell surface and causes Golgi fragmentation; KIF1C can protect Golgi membranes from fragmentation in the absence of an intact microtubule network, requiring both Rab6A-binding sites. |
In vitro microtubule binding assay; co-immunoprecipitation; siRNA knockdown; live-cell imaging; Golgi fragmentation assay; rescue experiments with binding-deficient mutants |
eLife |
High |
25821985
|
| 2015 |
GORAB missense mutations (p.Ala220Pro and p.Ser175Phe) found in gerodermia osteodysplastica patients fall within an internal IGRAB domain that binds both RAB6 and ARF5; RAB6 and ARF5 bind GORAB via the same domain; p.Ala220Pro abolishes interaction with both RAB6 and ARF5 and causes cytoplasmic mislocalization; p.Ser175Phe selectively impairs ARF5 binding and displaces GORAB to vesicular structures. |
Yeast two-hybrid; co-immunoprecipitation; immunofluorescence; mutagenesis with Golgi targeting assay |
The Journal of investigative dermatology |
High |
26000619
|
| 2015 |
BICD2 is a cytosolic factor required for Golgi targeting of Rab6A; BICD2 stabilizes GTP-bound Rab6A on Golgi membranes (FRAP shows reduced Rab6A exchange rate when BICD2 C-terminus is overexpressed); Rab6A and BICD2 are required for Golgi tubule fusion with ER in BFA-treated cells, confirming a role in COPI-independent Golgi-to-ER retrograde transport. |
Reconstitution of Golgi targeting in SLO-permeabilized HeLa cells; FRAP; BICD2 knockdown; BFA-induced Golgi-ER fusion assay |
Biochimica et biophysica acta |
High |
25962623
|
| 2015 |
RAB6A knockout mice die at an early stage of embryonic development, establishing RAB6A as an essential gene; Rab6-depleted MEFs show altered Golgi morphology, reduced Golgi-associated levels of Bicaudal-D and myosin II, delayed VSV-G secretion, protection against ricin toxicity, and impaired cell growth. |
Conditional knockout mouse; 4-OHT-induced Cre-mediated deletion in MEFs; immunofluorescence; secretion assays; toxin sensitivity |
Biology of the cell |
High |
26304202
|
| 2017 |
In melanocytes, the secretory pathway relies on RAB6 and its effector ELKS to directly transport and dock Golgi-derived carriers to melanosomes, delivering MART-1 and TYRP2/DCT cargo; this RAB6/ELKS-dependent pathway controls melanosome formation, maturation, and pigment synthesis; RAB6 KO mice display pigmentation defects. |
Live-cell imaging; siRNA knockdown; RAB6 KO mice; co-immunoprecipitation; cargo tracking to melanosomes |
Nature communications |
High |
28607494
|
| 2018 |
Rab6-dependent retrograde traffic of the LAT adapter from the plasma membrane through the Golgi-TGN controls TCR stimulation and immune synapse formation; this retrograde transport of LAT also depends on Syntaxin-16; in vivo Rab6 KO CD4+ T cells show impaired TCR stimulation. |
siRNA/shRNA knockdown in human cells; Rab6 KO mouse T cells; immunofluorescence; TCR stimulation assays; in vivo T cell activation |
The Journal of experimental medicine |
High |
29440364
|
| 2019 |
RAB6-positive post-Golgi carriers are the dominant class of secretory carriers regardless of cargo; RAB6 inactivation leads to broad reduction of protein secretion; exocytosis occurs at localized hotspots juxtaposed to focal adhesions, and the RAB6-dependent machinery plays an essential role in this spatial restriction. |
Synchronized secretion assay (RUSH system); live-cell imaging; RAB6 siRNA; tracking of multiple cargo types |
The Journal of cell biology |
High |
31142554
|
| 2020 |
In presynaptic nerve terminals, ELKS1 (a stationary presynaptic protein with Golgin homology) captures Rab6-marked vesicular cargo via direct Rab6 binding; this capturing mechanism can be transferred to mitochondria by mistargeting ELKS1 or Rab6; ELKS1 and Rab6 KO experiments establish the capturing function. |
Knockout and rescue experiments for ELKS1 and Rab6; live-cell imaging in neurons; mistargeting experiments to mitochondria; co-immunoprecipitation |
Cell reports |
High |
32521280
|
| 2021 |
Newly synthesized TrkB receptors traffic through the secretory pathway in Rab6-positive carriers; combined activity of kinesin-1 and kinesin-3 is required for the formation and processive anterograde transport of Rab6/TrkB axonal carriers; Rab6 regulates TrkB anterograde delivery into the axon. |
Microfluidic compartmental devices; inducible secretion assay (RUSH); live-cell imaging; siRNA knockdown of kinesins; hippocampal neuron cultures |
Developmental cell |
High |
33571451
|
| 2022 |
RAB6A/A' and RAB6B double knockout impairs apical localization of CRB3 in apical radial glia cells and induces delamination and ectopic division; post-Golgi transport of RAB6+ vesicles occurs toward microtubule minus-ends and depends on dynein; dynein activator LIS1 knockout phenocopies RAB6 double KO; identifying a RAB6-dynein-LIS1 complex for Golgi-to-apical surface transport. |
In situ subcellular live imaging in developing neocortex; conditional double knockout; CRB3 localization assay; dynein inhibition; LIS1 knockout |
EMBO reports |
High |
35979738
|
| 1999 |
Rab6 phosphorylation is induced in platelets by thrombin or phorbol esters via a PKC-dependent mechanism (blocked by Ro-31-8220); PKC phosphorylation of Rab6C increases GTP affinity ~3-fold and triggers translocation of Rab6 from platelet particulate fractions to cytosol, suggesting phosphorylation modulates Rab6 membrane association and functional interactions in vesicle trafficking. |
32P metabolic labeling; PKC inhibitor studies; subcellular fractionation; in vitro phosphorylation and nucleotide binding assays with recombinant Rab6C |
The Biochemical journal |
High |
10455022
|